ABDUL AZIZ SIDDIQUI to Camptothecin
This is a "connection" page, showing publications ABDUL AZIZ SIDDIQUI has written about Camptothecin.
Connection Strength
0.232
-
Precemtabart tocentecan, an anti-CEACAM5 antibody-drug conjugate, in metastatic colorectal cancer: a phase 1 trial. Nat Med. 2025 Oct; 31(10):3504-3513.
Score: 0.232
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.